Cadrenal Therapeutics Inc. Common Stock Analysis
| Analyst Ratings |
|
Average Target Price
|
3.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-1.80
|
-2.18
|
-0.38
|
-21.11%
|
|
2024-06-30
|
-1.80
|
-2.25
|
-0.45
|
-25.00%
|
|
2024-03-31
|
-0.07
|
-0.10
|
-0.03
|
-42.86%
|
|
2023-12-31
|
-0.08
|
-0.05
|
0.03
|
37.50%
|
|
2023-09-30
|
0.00
|
-0.08
|
0.00
|
0.00%
|
|
2023-06-30
|
0.00
|
-1.28
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-6.62
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-0.85
|
-0.85
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-4.53
|
|
2023-12-31
|
-8.03
|
|
2022-12-31
|
-0.91
|